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T cell receptor (TCR) engagement of peptide-major
histocompatibility complex (pMHC) is essential to
adaptive immunity, but it is unknown whether TCR
signaling responses are influenced by the binding
topology of the TCR-peptide-MHC complex. We
developed yeast-displayed pMHC libraries that
enabled us to identify new peptide sequences reac-
tive with a single TCR. Structural analysis showed
that four peptides bound to the TCR with distinct
3D and 2D affinities using entirely different binding
chemistries. Three of the peptides that shared a
common docking mode, where key TCR-MHC germ-
line interactions are preserved, induced TCR sig-
naling. The fourth peptide failed to induce signaling
and was recognized in a substantially different
TCR-MHC binding mode that apparently exceeded
geometric tolerances compatible with signaling. We
suggest that the stereotypical TCR-MHC docking
paradigm evolved from productive signaling geome-
tries and that TCR signaling can be modulated by
peptides that are recognized in alternative TCR-
pMHC binding orientations.
INTRODUCTION
A fundamental question about transmembrane receptors is
whether extracellular ligand binding architecture can influence
the nature of receptor activation. This is especially pertinent to
the ability of ab T cell antigen receptors (TCR) to sense and differ-
entially respond to the universe of peptides presented by major
histocompatibility complex (MHC). T cell activation is initiated
by TCR engagement of peptides displayed upon MHC (pMHC),
but subsequent signaling is the product of a complex series of
events involving the TCR-associated CD3, CD4, and CD8 core-
ceptors and assembly into multimeric clusters that ultimately
stimulate phosphorylation of intracellular immunoreceptor tyro-
sine-based activation motifs (ITAMs) (Beddoe et al., 2009; Gil
et al., 2002; Kuhns et al., 2006; van der Merwe and Dushek,I2011; Wucherpfennig et al., 2010). Given the wide range of
TCR binding geometries to peptide-MHC (pMHC) seen in TCR-
pMHC complexes that fall within the limits of a loosely conserved
docking orientation (Hahnet al., 2005;Rudolph et al., 2006), it has
so far appeared that a pMHC binding event of sufficient affinity
and duration can induce signaling regardless of the TCR-pMHC
complex architecture. Furthermore, the lack of correlation
between TCR-pMHC structural differences and the type of
T cell signals induced implies that different TCR-pMHC binding
modes do not generate distinct cellular signals (Ding et al., 1999).
It is clear that the chemistry of pMHC recognition by the TCR
does influence signaling by virtue of its effect on the binding
kinetics, half-life, affinity, and other biophysical parameters
(Alam et al., 1996; Kersh et al., 1998; Qi et al., 2006). A single
thermodynamic or kinetic parameter can sometimes qualita-
tively correlate with T cell responses (Aleksic et al., 2010; Govern
et al., 2010), and recent methodologies accounting for receptor
confinement and 2D receptor kinetics in the membrane have
shown correlations with activation (Huang et al., 2010; Huppa
et al., 2010). It is also generally accepted that clustering of the
TCR is critical for T cell activation within the immune synapse,
as pMHCmultimers are required for signaling in ab T cells (Brom-
ley et al., 2001; van derMerwe andCordoba, 2011). Bivalent TCR
and CD3 antibodies can substitute for pMHC to induce T cell
responses through clustering. Importantly, however, not all
TCR-CD3-specific antibodies stimulate T cells equally, suggest-
ing that the receptor geometry required for full activationmay not
be completely permissive (Janeway, 1995; Yoon et al., 1994), as
has been proposed (Cochran et al., 2001).
The TCR-pMHC docking geometry has been extensively
studied in an effort to understand MHC restriction (Garcia
et al., 2009; Godfrey et al., 2008; Marrack et al., 2008; Wilson
and Stanfield, 2005; Wucherpfennig et al., 2009). The compen-
dium of complex structures has revealed a loosely conserved
docking paradigm, or binding footprint. TCRs bind pMHC
roughly on a diagonal with the TCR Vb complementarity deter-
mining regions (CDRs) positioned over the MHC a1 helix and
peptide C terminus and the TCR Va CDRs positioned over the
MHC a2 (class I) or b1 (class II) helix or peptide N terminus,
thereby polarizing the TCR orientation on the MHC surface (Gar-
cia and Adams, 2005). There is awide range (±100) of docking
angles that conform to this canonical docking polarity. That suchmmunity 35, 681–693, November 23, 2011 ª2011 Elsevier Inc. 681
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that any constraints on signaling imposed by the geometry of
TCR-pMHC engagement are either quite loose or nonexistent.
The conservation of a TCR-MHC docking topology could be
a product of coevolved TCR-MHC germline specificity (Mazza
and Malissen, 2007), a consequence of extrinsic factors such
as coreceptor steric influences (Buslepp et al., 2003; Collins
and Riddle, 2008), or a product of CDR3-mediated peptide
selection during thymic education (Huseby et al., 2005). Recent
evidence supports the idea of a coevolved germline specificity
as an important determinant of the TCR-MHC binding mode
(Dai et al., 2008; Feng et al., 2007; Newell et al., 2011; Rubtsova
et al., 2009; Scott-Browne et al., 2009). In particular, a series of
structural and functional studies of the widely used murine
Vb8.2 germline segment showed that a similar set of TCR-
MHC interfacial contacts are formed, which probably represent
the evolutionary signature of TCR-MHC coevolution and appear
to play a role in orienting the TCR docking footprint on the MHC
(Dai et al., 2008; Feng et al., 2007; Garcia et al., 2009). An alter-
native view is that coreceptors bias the TCR for pMHC recogni-
tion and that TCRs can also recognize non-MHC antigens (Van
Laethem et al., 2007).
A related issue is how TCRs crossreact with the universe
of different peptide antigens they encounter during thymic
selection and peripheral surveillance (Felix and Allen, 2006;
Mason, 1998). Although we know that peptides have different
potencies to activate TCR signaling, we do not know whether
peptide crossreactivity is achieved through a single docking
footprint or whether a range of MHC docking modes exist that
would have disparate impacts on signaling induced by each
peptide (Felix et al., 2007; Yin and Mariuzza, 2009). Although
crossreactive TCR complexes so far have shown similar dock-
ing modes (Mazza et al., 2007), in many cases the peptides
shared key TCR contact residues (Ding et al., 1999; Macdonald
et al., 2009; Mazza et al., 2007), leaving open the question of
how sequences of unrelated peptides are accommodated by
the TCR.
Here we address the roles of TCR-pMHC binding geometry,
interface chemistry, affinity and kinetics in TCR signaling. We
describe the development of pMHC libraries in yeast that
allowed us to discover large collections of peptides reactive
with a given TCR. We measured the 2D and 3D interaction
parameters with four different peptides, assayed signaling prop-
erties, and determined the crystal structures of the complexes.
Our results suggest that there are geometric constraints on
TCR-MHC docking footprints compatible with signaling and,
more generally, TCR signaling can be modulated by perturba-
tions in the extracellular receptor-ligand architecture.
RESULTS
42F3 versus 2C Recognition of H2-Ld Presenting
the QL9 Peptide
The 42F3 TCR is derived from an alloreactive cytotoxic T
lymphocyte clone that recognizes the class I MHC molecule
H2-Ld presenting the peptide p2Ca933–940 of endogenousmouse
2-oxoglutarate dehydrogenase (Accession NP_035086) (Hornell
et al., 1999). 42F3 is related to another p2Ca-H2-Ld reactive
TCR, 2C, whose structure and binding properties have been682 Immunity 35, 681–693, November 23, 2011 ª2011 Elsevier Inc.extensively investigated (Colf et al., 2007; Garcia et al., 1996;
Holler et al., 2003; Sykulev et al., 1994). Both 42F3 and 2C also
recognize the related nonamer epitope of 2-oxogluterate dehy-
drogenase, QL9. The variable domains of 42F3 are Va3.3 and
Vb8.3 and therefore encode identical CDR1a and CDR2a and
nearly identical CDR1b and CDR2b to 2C (Figure 1A). However,
42F3 and 2C use different CDR3 sequences to recognize QL9-
H2-Ld (Figure 1A). Thus, these two TCR represent an ideal pair
to ask whether shared germline contacts would persist despite
their distinct CDR3-peptide contacts.
We solved the crystal structure of a 42F3 single-chain (sc) Fv in
complex with QL9-H2-Ld to 2.75A˚ resolution and found that it
shared a highly similar overall binding footprint compared to
the structure of 2C-QL9-H2-Ld (Figure 1B and Table S1, avail-
able online) (Colf et al., 2007), and Va binding contacts are
much more similar than Vb (Figure 1C). The Va3s in both TCRs
use a nearly identical set of contacts involving Tyr31a, Lys48a,
Tyr50a, Ser51a, and Gly52a to contact the H2-Ld a2 helix at
Glu154 and Tyr155 (Figure 1D). In both interfaces, Ser51a
hydrogen bonds to the MHC a2 helix backbone through its
side-chain hydroxyl, whereas Tyr31a and Tyr50a bury Tyr155
on the MHC surface (Figure 1D). For Vb8.2 and Vb8.3, the 2C
and 42F3 contacts with H2-Ld were highly divergent from one
another (Figure 1D). In both TCRs, Asn30b and Tyr50b make
contacts to the a1 helix, but the specific pair-wise residue
contacts were different (Figure 1D).
Identification of New 42F3-Reactive Peptides
We developed a method to screen for 42F3 binding to yeast-
displayed peptide-H2-Ld libraries (Figure 2A and Figure S1). A
variant of the ‘‘mini-MHC’’ platform, previously used for biophys-
ical studies (Colf et al., 2007; Jones et al., 2006), was fused
through a Gly-Ser linker to the N terminus of a nonamer peptide.
In order to accommodate the Gly-Ser linker without disrupting
TCR binding, we introduced a knob-to-hole mutation (Trp167
to Ala) at the end of the MHC a2 helix that created a notch for
the linker. The sc peptide-H2-Ld complexes were fused to the
C terminus of the yeast Aga2 protein (Gai andWittrup, 2007) (Fig-
ure 2A). Key to this strategy is that selections are based on direct
binding, in a cell-free system with recombinant TCR, devoid of
coreceptor or other potential endogenous influences on the
mode of recognition by the TCR. To select and stain the pMHC
yeast, we created TCR tetramers by complexing C-terminally
biotinylated TCR to streptavidin labeled with phycoerythrin
(SA-PE). We first verified that an H2-Ld platform containing the
cognate peptide QL9 would be specifically recognized by re-
combinant QL9-specific TCR by using flow cytometry. Using
an affinity-matured variant of 2C called m33 (Holler et al.,
2003), we observed bright peptide-dependent staining of yeast
displaying Aga2-QL9-H2-Ld (Figure S1) (wild-type 2C TCR also
showed positive staining). 42F3 tetramers poorly stained the
same yeast population (Figure S1); this indicates a weak affinity
for this TCR-pMHC complex and is consistent with our SPR
measurements (Figure S1).
We created three classes of libraries for yeast-displayed sc
peptides-H2-Ld. In the first, a random library consisted of
peptides whose sequence was limited only to known anchor
substitutions at the P2 and P9 anchor positions (Figure 2B)
(Udaka et al., 2000). All other positions were allowed full amino
Figure 1. The 42F3 and 2C TCRs and Their Interactions with QL9-
H2-Ld
(A) Primary sequence alignment of the six CDR loops of 42F3 and 2C TCRs.
(B) Ribbon representations of the 42F3 and 2C TCRs in complex with QL9-
H2-Ld aligned on theMHC (left), Top-down perspective of the six CDR loops of
2C and 42F3 (loops) on the surface of H2-Ld (right). 2C is a lighter shade, and
42F3 is a darker shade.
(C) Contacts made by the CDR3 loops to the QL9 peptide for both 2C (lighter
shaded colors) and 42F3 (darker shaded colors) TCRs are depicted.
(D) Contacts made by the Va and Vb CDR1 and CDR2 loops to the MHC
helices. The MHC is colored green, QL9 is colored yellow, TCRa is colored
firebrick and salmon, and TCRb is colored slate and pale cyan for 42F3 and 2C,
respectively. See also Figures S1 and S4.
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Iacid diversity by using a degenerate NNK nucleotide codon set.
A second library randomized only ‘‘up-facing’’ TCR contact resi-
dues in the peptide based on the crystal structure (P4, P5, P7,
and P8) (Figures 1C and 2B). A third library randomized
‘‘down-facing’’ MHC contact positions (P1, P2, P3, and P6)
(Figures 1C and 2B).
After several rounds of enrichment by fluorescence activated
cell sorting (FACS) with 42F3 tetramers (Figure S1), we recov-
ered sequences of individual clones from the libraries that
encoded diverse sets of peptides that were distinct from QL9
(Figure 2C). From the random library (Figures 2C and Figure S1),
we identified a single unique peptide sequence recognized by
42F3 (Figures 2B and 2C) that diverged from QL9 at every posi-
tion. The TCR contact set encoded only conservative mutations
at the P7 and P8 positions, whereas a new consensus arose at
the P4 and P5 positions (Figure 2C). Encoded in the enriched
MHC contact population were peptides that contained Trp at
the P6 position and highly favored Asn at P3 (Figure 2C). We
were surprised to find a Trp at P6, as it seemed incompatible
with the pocket in the H2-Ld groove that the Pro occupied in
QL9 (discussed below). BLAST sequence searches indicate
that none of the peptides discovered showed substantial simi-
larity to known proteins.
In Vitro Validation of Library-Derived Peptides
Binding to 42F3
We expressed the respective recombinant pMHC complexes
and evaluated affinity by using surface plasmon resonance
(SPR). Peptides selected from the combinatorial libraries bound
to the recombinant 42F3 with affinities typical for TCR-pMHC
interactions (KD5–50 mM) and with very fast kinetics (Figure S1
and Table S2). Only two of the tested pMHC complexes (3A1 and
5F1) (Figure S1 and Table S2) exhibited fittable kinetics. All of the
measured clones, including the random library clone 3A1, bound
with higher affinity (KD 4 mM) to 42F3 than did the original
agonist ligand presented by the sc QL9-H2-Ld (Figure 2C and
Figure S1). These selected peptides provided a diverse collec-
tion of chemical features and affinities to assay for differences
in signaling properties in a functional T cell assay.
T Cell Activation
We generated stable CD8+ and CD8 42F3 T cell hybridoma
transfectants by using retroviral-mediated gene transduction.
Antigen presenting cells (APCs) pulsed with five TCR contact
peptides produced IL-2 in the presence or absence of CD8,
consistent with their affinities and the affinity threshold (KD 1
to 5 mM) for CD8 independence (Chervin et al., 2009) (Fig-
ures 3A and 3B). In contrast, the four MHC contact peptides
tested and the native QL9 required CD8 for stimulating 42F3
T cells (Figures 3A and 3B). Although this result is expected for
the peptides QL9 and p5E8, which have lower affinities for the
42F3 TCR (KD 300 and 48 mM in the sc peptide-H2-Ld format,
respectively), the CD8 dependence was not expected for
peptides p5F1 and p5F2, which had affinities for 42F3 equal to
or better than the CD8-independent TCR contact peptides (Fig-
ure 2C). It is possible that the binding to the cell surface H2-Ld is
reduced for the MHC contact peptides compared to the TCR
contact peptides, and this property influences the requirement
for CD8. Consistent with this notion, the TCR contact peptidemmunity 35, 681–693, November 23, 2011 ª2011 Elsevier Inc. 683
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Figure 2. Yeast Surface Display of Peptide
Libraries Presented by H2-Ld
(A) Schematics of yeast-displayed pMHC libraries.
(Inset) The stick representation of QL9 from the
structure shown in Figure 1 showing the ‘‘up-
facing’’ recognition epitope of the 2C and 42F3
TCRs.
(B) 2D plot of the final enriched yeast populations
of the random, TCR contact, and MHC contact
libraries enriched by FACS. Residues varied in
each library are indicated in red where X repre-
sents 32 codons (NNK) encoding all 20 amino
acids. Positions with fixed sequence are indicated
in black.
(C) Sequences of 42F3 peptides isolated from
individual yeast colonies. Selected KD measure-
ments are from SPR equilibrium values. See also
Figure S1.
Immunity
TCR-pMHC Docking Geometry Influences Signalingp4B3 was active at low peptide concentrations in the presence
of CD8 (Figure S2A).
A peptide from the random library, SPLDSLWWI (p3A1), failed
to induce a strong IL-2 response for either 42F3 T cell line up to
a concentration of 100 mM peptide (Figures 3A and 3B and
Figures S2B and 2C), despite having one of the highest
measured SPR affinities for the 42F3 TCR (Figures 2C and Fig-
ure S1). To determine whether the lack of IL-2 stimulation was
due to inefficient loading of p3A1 onto H2-Ld on the APC, we as-
sayed p3A1’s ability to compete with a biotinylated agonist for
MHC binding on the APC surface (Figure S2A). We labeled the
biotinylated agonist with SA-PE and measured APC binding by
using flow cytometry (Figure S2D). The unlabelled p3A1 peptide
effectively competed for MHC binding on the APCs at experi-
mental conditions (10 mM) comparably to several agonist
peptides (Figure S2E), indicating loading in H2-Ld. We then
asked whether peptide-loaded recombinant H2-Ld molecules,
as opposed to peptide-loaded H2-Ld on APC, could activate
42F3 transfectants. Recombinant H2-Ld-Ig dimers presenting
p3A1 failed to stimulate the 42F3 T cells, whereas agonist
peptides loaded in the H2-Ld-Ig dimers effectively stimulated684 Immunity 35, 681–693, November 23, 2011 ª2011 Elsevier Inc.(Figure 3C). Finally, we asked whether
the lack of stimulation was due to an
APL type of downstream antagonism
that could inhibit the function of copre-
sented agonist peptide (Hogquist et al.,
1994; Stone et al., 2011). However,
agonist (p4B3)-induced activation was
not influenced by the p3A1 peptide pre-
sented by the same APC (Figure 3D).
The p3A1 peptide, then, binds to 42F3
with comparable affinity to agonists but
does not appear to deliver either an acti-
vating or inhibitory signal.
2D Affinity and Tetramer Binding
to Cells
Recently, kinetic measurements using
intact T cells have been shown to corre-
late with proliferative T cell responsesfor the 5c.c7 and OT1 TCR systems (Huang et al., 2010; Huppa
et al., 2010). The advantage of this approach over 3D kinetic
measurements such as SPR is that the membrane confinement
properties of the TCR and pMHC are preserved. Because 3D
kinetics of the 42F3 peptides poorly correlated with activation,
we carried out experiments to measure the 2D kinetic parame-
ters of p3A1-H2-Ld binding to CD8ab 42F3 T cells and
compared it to several agonists (Figure 4A and Figure S3). In
this format, 42F3 transfectants are used as the source of TCR,
and SA-coated red blood cells are decorated with the same
N-terminally biotinylated sc peptide-H2-Ld complexes used for
SPR measurements. In situ, the agonist peptides bound to the
T cells with fast Ackon and fast 2D-koff creating greater than
two-fold difference in 2D affinity compared to p3A1 (Figure 4A),
consistent with the IL-2 activation (Figures 3A and 3B). Although
all measured peptides had fast off-rates (t1/2 = 0.2–0.09 s), the
p3A1-H2-Ld interaction had the slowest 2D-koff (Figure S3).
The rank orders of peptide affinities in the 2D format correlated
better with peptide biological activity (Figure 3) than affinities
measured by 3D (Figure 4B and Figure S3). Both the lack of
42F3 T cell activation and the weak 2D-Ackon (Figure S3) suggest
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Figure 3. T Cell Activation by Peptide
Antigens
IL-2 release for (A) CD8-negative and (B) CD8-
positive 42F3 T cells stimulated by peptide-loaded
10 mMAPCswith an effector:target ratio of 1:1. Full
dose-response curves are shown in Figure S4.
(C) IL-2 release for CD8+ 42F3 T cells stimulated
with peptide-loaded H2-Ld-Ig dimers.
(D) p3A1 antagonist assay where 42F3 T cells
stimulated with 100 nM p4B3 were assayed for
IL-2 production over a range of p3A1 concentra-
tions. The stimulatory CD3 (2C11) antibody and/or
the endogenous peptide QL9 were used to assay
IL-2 sensitivity in each ELISA. The addition of no
peptide and the irrelevant H2-Ld restricted MCMV
epitope (YPHFMPTNL) were used to assay
peptide-independent IL-2 production in each
experiment. Peptides showing CD8 dependence
were colored cyan; peptides showing CD8 inde-
pendencewere colored green. See also Figure S2.
The error bars indicate ± standard error of the
mean.
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T cell surface compared to isolated TCR in solution.
We further investigated the reduced 2D affinity of the p3A1
interface by probing the epitope availability on the peptide-
loaded APCs and the 42F3 T cell line, respectively. 42F3 tetra-
mers stain p3A1-loaded APCs (Figure 4C), whereas p3A1-
H2-Ld tetramers did not stain 42F3 T cells (Figure 4D). TCR
tetramer staining is in good correlation with the 3D affinities mea-
sured by SPR (Figure 4E), whereas the pMHC tetramer binding
correlated better with the 2D affinities (Figure 4F). Collectively,
the 2D and tetramer staining experiments show that the engage-
ment of 42F3 TCR on cells appears to be spatially constrained
during engagement of p3A1 compared to agonist peptides.
When the TCR was not presented in the context of a T cell
membrane during 3D SPR measurements, either as a tetramer
or monomer in solution, the binding affinities and kinetics of
several agonist peptides and p3A1 weremore similar (Figure 4E).
Structural Features of pMHC Recognition
Wedetermined crystal structures of the 42F3 TCR bound to each
of the four peptide-H2-Ld complexes: p3A1-H2-Ld (2.1 A˚), QL9-
H2-Ld (2.75 A˚), p4B10-H2-Ld (2.9A˚), and p5E8-H2-Ld (3.1A˚) (Fig-
ure 5A, Figure S4, and Table S1). Each peptide was well defined
in the electron density and presented a unique structural epitope
and chemical surface to the TCR (Figure 5A and Figure S4). In
fact, the interaction chemistries of each of the four peptides
with the 42F3 CDR3s were nearly entirely distinct, ranging from
largely hydrophobic (p3A1 and QL9) to polar-hydrophobic
(p5E8) to charged (p4B10), highlighting a remarkable ability of
a single binding site to accommodate a range of structural chem-
istries (Figure 5A). Although we do not describe each interface
here in detail, of particular note are unexpected conformationsImmunity 35, 681–693, Nof the p5E8 and p3A1 peptides, which
contain either a Trp or Leu substitution
at P6, respectively (P6 is Pro in QL9) (Fig-
ure 2C). In p5E8, the peptide backbone
has flipped, such that P6-Trp is now anup-facing TCR contact instead of a down-facing MHC anchor,
apparently because of a lack of space for the Trp side chain in
the H2-Ld peptide binding groove (Figure 5A). The p5E8
P5-Phe, a TCR contact in QL9, is flipped down into the MHC
anchor pocket previously filled with the QL9 P6-Pro (Figure 5A).
Thus, the TCR epitope of the MHC contact peptide is completely
altered even though none of the TCR contact residues were
randomized in this library. In the case of p3A1, the P6-Leu also
becomes a TCR contact. However, the p3A1 peptide fails to fill
the P6 pocket, instead forming an arched conformation
(Figure 5A and Figure S4). These observations highlight the
unpredictable manifestations of peptide substitutions on T cell
recognition and that MHC anchors can greatly impact the TCR
epitope in unexpected fashions. Superposition of the four TCR
structures from the complexes shows that CDR3 conforma-
tional variability in 42F3 primarily lies in CDR3a, not CDR3b (Fig-
ure 5B). This illustrates TCR crossreactivity through a relatively
rigid TCR binding site in the absence of significant CDR3b
flexibility.
TCR-pMHC Docking Geometry
All three of the agonist peptides share a similar overall docking
footprint where the Va and Vb are positioned diagonally across
the surface of the pMHC (Figure 6A). In contrast, the nonstimula-
tory p3A1 docking footprint diverged markedly (Figures 6A and
7A). In the agonist complexes, comparison of the Va3.3 contact
points with the a2 helix revealed the same conserved contact set
previously observed for four 2C complexes with agonist
peptides (Figures 1D and 6B) involving Va germline residues
Lys48a, Tyr31a, Tyr50a, and Ser51a (Figure 6C and Figure S5).
Through small-scale rolling and tilting adjustments of the TCR
in each complex, Va3.3 formed a variety of auxiliary polar andovember 23, 2011 ª2011 Elsevier Inc. 685
AC
D
E
B Figure 4. 2D and 3DMeasurements of pMHC Inter-
actions with 42F3
(A) 2D affinities (AcKA) derived from T cell adhesion
frequency and thermal fluctuation assays with pMHC-
coated RBCs.
(B) SPR-derived 3D affinities (expressed as KA for
comparison to 2D) with sc H2-Ld constructs (p3A1 has the
highest affinity and QL9 the lowest). Direct comparison of
2D and 3D kinetics is also shown in Figure S5.
(C) Fluorescent 42F3 tetramer staining of peptide-loaded
APCs.
(D) Fluorescent sc H2-Ld tetramer staining of 42F3 T cells.
Peptides presented by H2-Ld were CD8-dependent (cyan)
agonists, CD8-independent agonists (green), or the non-
stimulatory peptide p3A1 (red).
(E) Correlation between TCR tetramer staining and the 3D
affinity of the pMHC ligand is compared to the correlation
between pMHC tetramer staining and the 2D affinity (F).
Open bars represent tetramer staining, and closed bars
represent 2D and 3D affinities shown in (A). See also Fig-
ure S3.
For (A, B, E, and F) the error bars indicate ± standard error
of the mean.
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retaining a shared core of contacts (Figure 6C and Figure S5).
For example, a C-terminal roll in the QL9 complex allowed
Lys48a to hydrogen bond to the MHC a2 backbone, whereas
in the p4B10 complex, the Vamakes additional hydrogen bonds
from Tyr50a and Ser51a to the Glu154 carboxyl group (Fig-
ure S5). These adjustments show that the Va germline contacts
adapt to peptide-specific sequence differences while maintain-
ing a strikingly conserved contact set with the MHC a2 helix
(Figures 6B and 6C). This peripheral plasticity in the midst of
a conserved core interaction network was also noted for the
Vb8/I-A complexes (Dai et al., 2008; Feng et al., 2007).
The structures show that 42F3 Vb8, which appeared to have
key germline contacts in prior Vb8 complexes, does not form686 Immunity 35, 681–693, November 23, 2011 ª2011 Elsevier Inc.many shared or conserved contacts with the
H2-Ld a1 helix between the different peptide
complexes (Figures 6A and 6B and Figure S5).
Although Tyr50b and Asn31b continue to play
prominent roles in each of these interfaces,
and the overall location of the Vb-MHC contact
patch is very similar between the structures
(Figure 6B), the pairwise contacts are chemi-
cally distinct (Figure S5). The residue Tyr50b,
central to the previously described Vb8.2-I-A
‘‘codon’’ (Feng et al., 2007), uses a variety of
side-chain rotamers to recognize the different
pMHC surfaces (Figure S5). In the p5E8
complex, the Tyr50b rotamer lies planar to
the a1 helix as seen in the 2C-QL9-H2-Ld
complex (Figure S5). In the QL9 and p4B10
complexes, Tyr50b points deep into the
peptide binding groove to make a hydrogen
bond to peptide at the P8-Asp position (Fig-
ure S5). These structures highlight the impor-
tant role and remarkable ability of Tyrosineresidues in TCR V-regions to form multifarious germline MHC
contacts (Garcia et al., 2009; Marrack et al., 2008).
A Germline-Encoded Motif for TCR Va3 Recognition
of H2-Ld
Analysis of seven total TCR-peptide-H2-Ld complexes, three
42F3 agonist complexes, a 2C complex with H2-Ld (Colf et al.,
2007), and three CDR3a mutants of 2C (m6, m67, m13) in
complex with H2-Ld (Jones et al., 2008), revealed a conserved
contact set between these Va3 CDRs 1a and 2awith the a2 helix
of H2-Ld (Va3.3 in the case of 42F3 and Va3.1 in the cases of 2C,
m67, m6, and m13) (Figure 6B). Central to the Va3.1 and Va3.3
motif are Tyr31a and Tyr50a van der Waals contacts to H2-Ld
Tyr155 and the TCR Ser51a hydrogen bond to the helical
Immunity
TCR-pMHC Docking Geometry Influences Signalingbackbone at H2-Ld Glu154 (Figure 6C). Tyr31a and Tyr50a are
among the most energetically important in the 2C TCR interac-
tion with QL9-H2-Ld (Manning et al., 1998). The Va3.3 interaction
motif accommodates slight differences in TCR roll and tilt,
a variety of CDR3 sequences (2C, m6, m67, m13, and 42F3),
and considerable peptide variation (QL9, pB10, and pE8) (Fig-
ure 6C). We conclude that 2C and 42F3 TCR germline recogni-
tion of H2-Ld is centered on a Va-centric ‘‘codon,’’ as compared
to the apparently Vb-centric recognition of the class II I-A
complexes (Figure 6C). It appears that different TCR complexes
can be more or less Va- or Vb-centric in the utilization of
conserved germline contacts.
Unusual Docking Geometry of the p3A1
Nonstimulatory Complex
p3A1 peptide recognition required a global reorientation of the
entire 42F3-H2-Ld interface compared to the agonist complexes,
rotating 38 clockwise and translating 7A˚ from the center of
the groove so that 42F3 lies over the a1 helix, resulting in
a TCR orientation nearly parallel to the peptide (Figures 6A and
7A). 42F3 recognition of H2-Ld did not involve the Va codon
seen in the stimulatory complexes (Figures 6A and 6C). Instead,
the TCR Va3.3 makes a single contact to the a2 helix at H2-Ld
Tyr155 through 42F3 Tyr50a, and straddles both helices of the
peptide binding groove, forming a hydrogen bond between
42F3 Thr29a to H2-Ld Gln65 of the a1 helix (Figure 7B and
Figure S5). The parallel docking topology also enables Vb8.3
to straddle the groove, with contacts on both the a1 and a2
helices, including Tyr50b interacting with the a2-helix. (Fig-
ure 7B and Figure S5). Also, a slightly squeezed conformation
of p3A1 peptide binding groove results in a narrower distance
between a1 and a2 helices, facilitating Asn31b bridging the
MHC groove to form a bifurcated hydrogen bond with both
Thr80 of the H2-Ld a1 and Lys146 of a2 helices (Figure 7B).
The docking footprint appears to be at the extreme clockwise
end of the range compared to other class I agonist TCR-pMHC
complexes (Figure 7C). Importantly, despite the unusual MHC
footprint, 42F3 CDR3a and CDR3b are focused on the peptide,
and the global polarity of the complex does not violate the
previous paradigm of Va lying over the N-terminal end of the
groove and Vb lying over the C-terminal end (Figures 5A and 7A).
DISCUSSION
In a classical study, Janeway and colleagues showed that
different TCR and CD3 antibodies had varied agonistic proper-
ties, prompting the suggestion that TCR signaling was depen-
dent upon the overall architecture of the TCR-CD3 complex
(Janeway, 1995; Yoon et al., 1994). In contrast, other studies,
such as those using chemically defined oligomerization agents
concluded that intermolecular proximity alone was the key
determinant for TCR activation (Cochran et al., 2001). Here we
developed a peptide-based approach to investigate the interre-
lationship between TCR-pMHC binding chemistry, docking
geometry, 2D and 3D binding parameters, and signaling. Our
principal findings are that (1) not every binding orientation is
compatible with signaling and (2) a TCR utilizing entirely distinct
chemistries to recognize different peptides exhibits highly
persistent germline-mediated contacts. That alternative TCR-IMHC binding modes are accessed by certain peptides is an
important extension to prior studies on TCR crossreactivity
where the germline MHC contacts have largely remained intact,
albeit often undergoing adjustments (Borbulevych et al., 2009;
Ding et al., 1999; Garcia et al., 1998; Macdonald et al., 2009;
Mazza et al., 2007; Reiser et al., 2003; Wucherpfennig et al.,
2009; Yin and Mariuzza, 2009). Here, we find that peptide cross-
reactivity can influence signaling through gross alterations of
TCR binding geometry.
What is the mechanistic basis for the p3A1 lack of activity?We
do not know whether the manifestation of an altered TCR dock-
ing topology as a lack of signaling is reflective of conformational
change(s), altered CD3 associations, clustering, or other events
known to be critical for TCR signaling (van der Merwe and
Dushek, 2011; Gil et al., 2002; Minguet et al., 2007). Although
not providing detailed answers, the 2D versus 3D experiments
are informative. The 2D method clearly demonstrated that
p3A1-H2-Ld is binding to the 42F3 TCR on the cell surface, albeit
with lower 2D affinity than the agonist peptides. The p3A1-H2-Ld
boundwith high affinity to solublemonomeric 42F3 by using SPR
(3D), but neither p3A1-H2-Ld tetramers or p3A1-loaded dimers
(H2-Ld-Ig) stained or stimulated 42F3 T cells, respectively.
Thus, when cellular spatial constraints are absent, there is
a high affinity interaction between p3A1-H2-Ld and 42F3, yet
each of the three constrainedmethods yielded reduced signaling
and binding by p3A1 versus a panel of agonist peptides. Collec-
tively, these 2D and 3D data suggest that the spatial orientation
of the prebound states of the TCR and pMHC on the cell
membrane are critical factors determining TCR-MHC associa-
tions and TCR signaling.
We can propose several speculative but equally plausible
models for p3A1’s lack of activity. In one, in order for the TCR
to engage in the unusual H2-Ld docking angle on the APC, it is
required to twist out of a signaling productive oligomeric or ultra-
structural arrangement (Figure 7D). The docking angle in the
p3A1 complex may have exceeded the allowable range of
signaling competent binding modes. The minimal signaling
TCR ligand is a pMHC dimer (Boniface et al., 1998; Cochran
et al., 2001), and a study proposed a specific topology of the
corresponding ab-TCR-CD3 dimer (Kuhns et al., 2010). Engage-
ment of p3A1 may either produce unproductive TCR-pMHC
dimers or inhibit, or poison, the formation of productive p3A1
dimers by blocking the recruitment of a second TCR or MHC,
the latter scenario being anoligomer exclusionmodel (Figure 7D).
In short, the p3A1 docking topology may be incompatible with
the TCR-CD3 signaling dimer architecture (Figure 7D). However,
we currently know very little about the ultrastructure of clustered
TCR and how these geometric considerations influence the
engagement of distinct pMHC orientations. Because the
majority of class I MHC on the APC surface present self-
peptides, it is rare for a T cell receptor dimer to encounter two
foreign agonist peptides in MHC simultaneously. Rather,
T cells can apparently overcome this limitation by signaling via
an MHC pseudodimer containing only one agonist peptide, but
whether there are geometric constraints placed upon agonist
signaling by the endogenous coagonist is not known (Juang
et al., 2010). Unclustering the TCR by disrupting lipid rafts or
actin polymerization has been shown to change the 2D affinity
for TCR-pMHC (Huang et al., 2010; Huppa et al., 2010),mmunity 35, 681–693, November 23, 2011 ª2011 Elsevier Inc. 687
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Figure 6. Stimulatory TCR-pMHC Docking Geom-
etries Mediated by a Va3 Germline ‘‘Codon’’
(A) The TCR docking footprints of 42F3 when recognizing
three stimulatory and one nonstimulatory peptide. Dashed
lines connecting the Ca of Y50a, and Y50b carbons are
used to illustrate the relative orientations of the respective
complexes 42F3-QL9-H2-Ld (black) and 42F3-p3A1-
H2-Ld (red). Black and red dots indicate the center of
masses of the 42F3 TCR in the QL9 versus p3A1
complexes, respectively.
(B) The convergent docking footprints of seven different
Va3Vb8 TCR complexes with H2-Ld-peptide agonists
including four previous 2C complexes and three 42F3
complexes recognizing stimulatory peptides. Inset (top) is
a color-coded legend for each TCR and the corresponding
peptide recognized in each H2-Ld complex. Inset (bottom)
is a contact map depicting conserved contacts between
the Va3.1 or Va3.3 and the a2-helix in seven agonist
complexes.
(C) Detailed contacts of CDR1 and CDR2 of the Va3.1 and
Va3.3 to the a2 helix (green) in seven agonist complexes.
van der Waals contacts are depicted as sticks, whereas
hydrogen bonds and salt bridges are depicted with
dashed lines. See also Figure S5.
Immunity
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antigen recognition. It is also possible that simultaneous, multi-
point attachment of CD3, CD8, and MHC to the TCR within
a unitary signaling complex in these signaling clusters can occur
only within a range of TCR-pMHC docking angles that are
accommodated by canonical orientations. The p3A1 docking
angle may have exceeded these tolerances so that in order for
42F3 to bind to p3A1, either the signaling competent TCR dimer
or oligomer or its associations with coreceptors (CD3, CD4 or
CD8) are disrupted. It is puzzling that although the association
of p3A1 was weaker in situ than agonists, the resulting 2D
AcKa, Ackon, and koff were equivalent to that of stimulatory
pMHC associations on OT1 CD8+ T cells (Huang et al., 2010).
Thus, the lack of activation is not fully explained by decreased
2D kinetics alone.
That the nonstimulatory peptide is not a naturally occurring
sequence, and binds in an unconventional orientation, has
potential implications for the notion of germline TCR-MHC
coevolution. Germline specificity presumably evolved in the
context of coreceptors and natural peptide antigen sequences,
contributing to productive TCR-MHC-CD3-CD8 (or CD4)-sig-
naling geometries. p3A1, being an unnatural peptide could
have accessed geometric limits of TCR-pMHC orientationFigure 5. Crossreactivity through Distinct Peptide Recognition Chemistries by the 42F3
(A) Left: ribbon diagrams of the VaVb domains of 42F3 bound toQL9, p5E8, p4B10, and p3A1 presente
of the respective TCR CDR3 loops with the presented peptides (MHC is colored green, peptides are c
CDR3b loop contacts. The TCR structures in the p3A1, p4B10, and p5E8 complexes included cons
(B) Aligned structures of the 42F3 TCR variable domains show superpositions of CDR loop structures f
(QL9), lightpink (p5E8), raspberry (p4B10), andmagenta (p3A1). The42F3b is colored slate (QL9), light bl
Immunity 35, 681–incompatible with signaling on T cells. In this
respect, the synthetic approach may sidestep
evolutionary pressures experienced in the con-
text of the endogenous peptide milieu to
achieve an unnatural docking footprint. How-ever, it is unclear whether the docking mode we see for p3A1
is germline-encoded, or not, because the overall canonical
binding polarity is not violated compared to other TCR-pMHC
complexes, and important germline residues (e.g., Tyr31a,
Tyr51a, Tyr50b) still mediate the MHC contacts. It is intriguing
to consider that nonproductive peptides and binding modes
analogous to p3A1 could exist in nature but have evaded exper-
imental detection using TCR-signaling-based identification
methods.
With reference to prior studies showing conserved germline
Vb8.2-I-A contacts in over eight TCR-pMHC complexes, the
Va3.3 and Va3.1 recognition of H2-Ld shown here for seven
different agonist peptide complexes (42F3 and 2C) illustrates
that both Vb- and Va-centric germline motifs, which we have
euphemistically referred to as ‘‘codons,’’ exist. In the case of
H2-Ld, the Va codon centers on MHC position 155, which
has been previously identified as a component of the MHC
restriction triad, and is contacted in nearly all class I TCR-
pMHC complex structures (Tynan et al., 2007), highlighting
the astonishing ability of each V segment to form structurally
distinct sets of contacts with different classes of MHC. Such
diversity appears conserved within a given MHC but very
different across different MHC.TCR
d by the a1a2 of H2-Ld. Center: accompanying interactions
olored yellow). Right: 2D contact maps of 42F3 CDR3a and
tant domains, but these are not depicted in the figures.
rom the four different complexes. 42F3a is colored firebrick
ue (p5E8), cyan (p4B10), andblue (p3A1).SeealsoFigureS4.
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Figure 7. Altered TCR-pMHC Docking Geometry in a Nonstimulatory Complex
(A) The docking footprint of 42F3 recognizing the p3A1 nonstimulatory peptide. As in Figure 6, a dashed line connects the Ca of Y50a and Y50b carbons
(red, compared to black for stimulatory complexes) to illustrate the binding orientation.
(B) The germline contacts made by either the Va (left panel) or the Vb (right panel) to the MHC helices of H2-Ld presenting p3A1. Residues making van der Waals
contacts are represented as sticks and dashed lines represent hydrogen bonds.
(C) Range of docking footprints in 40 Class I TCR-pMHC agonist complexes (firebrick and slate) aligned on the MHC together with the nonstimulatory p3A1
peptide footprint (magneta and blue). The CDR loops of 42F3 in the p3A1 complex are highlighted as thick tubes, and the docking angle is shown as a dashed
yellow line, and the center of mass between the CDR3a and CDR3b of 42F3 is denoted by the yellow dot.
(D) Theoretical models for how TCR-pMHC docking geometry in the p3A1 (red peptide) complex could influence signaling compared to the productive agonist
(green peptide).
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suggests that peptides can influence the TCR to form dissimilar
germline contacts with MHC. On the other hand, three of the four
peptides are recognized in a convergent and apparently germ-
line-encoded Va docking position. That this convergence was
achieved with distinct peptides selected in the absence of core-
ceptors strongly supports the influence of an intrinsic MHC
specificity. We suggest these seemingly incongruent results
are consistent and reconcile the relative roles of intrinsic (germ-690 Immunity 35, 681–693, November 23, 2011 ª2011 Elsevier Inc.line engrafted specificity) and extrinsic (steric influence of
coreceptors) in positioning the TCR-MHC docking orientation.
Germline TCR-MHC specificity probably arose within the
context of a higher order TCR-CD3-MHC-CD8 (or CD4) complex
where the TCR was positioned topologically, through multipoint
attachment, for productive signaling. In this sense, the interfacial
TCR-MHC contacts mediating signaling competent binding
geometries have been selected during evolution. These higher
order geometric constraints would certainly involve coreceptor
Immunity
TCR-pMHC Docking Geometry Influences Signalinginfluences that could enforce the invariant TCR-MHC docking
polarity. However, this interfacial specificity was engrafted in
the germline, which obviated the need for coreceptors to actively
position the TCR.
Taken together, our data demonstrate a relationship between
TCR-MHC docking geometry, peptide crossreactivity, germline
bias, and signaling. The innate crossreactivity of T cell recogni-
tion is apparently more than a means of simply enabling a struc-
turally agnostic bimolecular interaction between a TCR and
MHC. Rather, the chemistry of the peptide can modulate dock-
ing footprints as well as kinetics and affinity, which in turn can
modulate signaling. Our future studies will attempt to more
deeply understand the generality and ultrastructural mechanism
of this unexpected finding.EXPERIMENTAL PROCEDURES
Cloning and Expression of 42F3 TCR
RNA was isolated from primary 42F3 T cells in order to prepare cDNA of the
TCR a and b chains. For recombinant expression, the V regions of the a and
b chain were spliced by overlapping extension to form a Va-(Gly4Ser)4-Vb
scFv expressed in pET22b to allow for periplasmic secretion. Two stabilizing
mutations in the Va3.3 and five mutations in the Vb8.3 were introduced as
previously described for 2C (Colf et al., 2007). For full-length ectodomains,
the wt Va3.3 and Vb8.3 regions of the 43F3 TCR were fused in frame with
human constant domains (Boulter et al., 2003) and expressed in baculovirus
with a C-terminal acidic GCN4 zipper-BAP-6xHis tag (a) or a C-terminal basic
GCN4-zipper-6xHis tag (b).
Yeast-Displayed H2-Ld-Peptide Libraries
H2-Ld was displayed on yeast by converting a minimal a1a2 variant of H2-Ld,
called m31, that was previously used for structural studies (Jones et al., 2006)
into a sc pMHC with a C-terminal tethered peptide (Aga2-LdW167A-pep) by
incorporating the mutation W167A. A degenerate primer containing the
peptide was used to amplify by PCR combinatorial libraries. The yeast libraries
were constructed by standard methods (Chao et al., 2006). The number of
transformed yeast for each library were 1.8 3 108, 1.0 3 108, and 5.7 3 107
for the Random, TCR contact and MHC contact libraries, respectively.
42F3 Tetramer Selection of Yeast Clones
After induction of the yeast libraries, the yeast cells were incubated with
470 nM preformed 42F3 tetramers assembled on SA-PE (Invitrogen) and
1:100 dilution of anti-HA-Alexa488 (Invitrogen) sorted on a FACS Aria (BD).
During the first round of selections, the brightest 2.5% of the TCR-Tet+/HA+
population was sorted into a single culture. The sorted cells were grown over-
night and the process repeated. After the first round of selection, the brightest
1% of TCR-Tet+/HA+ was sorted until greater than 10% of the yeast popula-
tion could be resolved from the unstained population by flow cytometry.
2D Kinetics Measurements
Procedures for coupling pMHC to red blood cells (RBC) or glass beads have
been described (Huang et al., 2007). Briefly, RBCs were first biotinylated with
biotin-X-NHS (EMD chemicals) and then reacted to streptavidin; borosilicate
beadswere first cleaned, silanized, and then reacted to streptavidin-maleimide
(Sigma-Aldrich, St. Louis, MO). Streptavidinized RBC or beads were finally
coupled to the sc pMHC through their biotin tags. Site densities of TCR on
hybridoma cells and pMHC on RBC or bead surfaces were measured with
flow cytometry. Micropipette adhesion frequency assay and thermal fluctua-
tion assay were carried out in a similar manner as previously described (Chesla
et al., 1998) and described in detail in Supplemental Experimental Procedures.
Additional Methods
More detailed descriptions of methods for protein expression and purification,
SPR measurements, protein crystallization and structure refinement, T cellIactivation assays, and MHC-TCR tetramer staining can be found in the
Supplemental Information.ACCESSION NUMBERS
Atomic coordinates have been deposited in the Protein Data Bank under the
accession numbers 3TPU, 3TJH, 3TFK, and 3TF7 for the 42F3-p5E8, 42F3-
p3A1, 42F3-p4B10, and 42F3-QL9 TCR-pMHC complexes, respectively.SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
five figures, and two tables and can be found with this article online at
doi:10.1016/j.immuni.2011.09.013.
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